Welcome to LookChem.com Sign In|Join Free

CAS

  • or

600638-86-6

1-(3-ISOPROPYL-3H-IMIDAZOL-4-YL)-ETHANONE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

600638-86-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 600638-86-6 Structure

  • Basic information

    1. Product Name: 1-(3-ISOPROPYL-3H-IMIDAZOL-4-YL)-ETHANONE
    2. Synonyms: 1-(3-ISOPROPYL-3H-IMIDAZOL-4-YL)-ETHANONE;Ethanone, 1-[1-(1-methylethyl)-1H-imidazol-5-yl]- (9CI)
    3. CAS NO:600638-86-6
    4. Molecular Formula: C8H12N2O
    5. Molecular Weight: 152.19368
    6. EINECS: N/A
    7. Product Categories: ACETYLGROUP;ISOPROPYL;AMINETERTIARY
    8. Mol File: 600638-86-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-(3-ISOPROPYL-3H-IMIDAZOL-4-YL)-ETHANONE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-(3-ISOPROPYL-3H-IMIDAZOL-4-YL)-ETHANONE(600638-86-6)
    11. EPA Substance Registry System: 1-(3-ISOPROPYL-3H-IMIDAZOL-4-YL)-ETHANONE(600638-86-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 600638-86-6(Hazardous Substances Data)

600638-86-6 Usage

Structure

Ketone derivative containing an imidazole ring

Medicinal Chemistry

Used in the development of pharmaceuticals and organic compounds

Drug Development

Building block for creating new therapeutic agents

Cancer

Development of drugs targeting cancer cells

Diabetes

Research and development of treatments for diabetes

Neurological Disorders

Creation of drugs for neurological conditions

Biological Sciences

Research and development of new therapeutic agents

Pharmaceutical Industry

Synthesis of pharmaceuticals and organic compounds

Reactivity

Can undergo various chemical reactions due to the presence of the ketone and imidazole groups

Solubility

Soluble in organic solvents like ethanol, methanol, and acetone

Stability

Stable under normal conditions, but sensitive to heat, light, and moisture

Handling

Use gloves, safety goggles, and a lab coat when handling the compound

Purity

Typically synthesized with high purity for use in research and pharmaceutical development

Check Digit Verification of cas no

The CAS Registry Mumber 600638-86-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,0,6,3 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 600638-86:
(8*6)+(7*0)+(6*0)+(5*6)+(4*3)+(3*8)+(2*8)+(1*6)=136
136 % 10 = 6
So 600638-86-6 is a valid CAS Registry Number.

600638-86-6Relevant articles and documents

METHOD FOR PRODUCING 1-SUBSTITUTED-5-ACYLIMIDAZOLE COMPOUND

-

Page/Page column 10; 11, (2008/12/05)

An industrially advantageous process for preparing 1-substituted 5-acylimidazole compounds can be performed by reacting an N-substituted amidine compound or a salt thereof with a ketone compound in the presence of a base.

DERIVATIVES OF 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE WITH CDK INHIBITORY ACTIVITY

-

Page/Page column 54, (2008/06/13)

Compounds of the formula (I): wherein R1, R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.

4- IMIDAZOLYL SUBSTUITED PYRIMIDINE DERIVATIVES WITH CDK INHIBITIORY ACTIVITY

-

Page/Page column 58, (2010/02/07)

Compounds of the formula (I): wherein R1, R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 600638-86-6